T/CACM 1407-2022 Colorectal Cancer Chemotherapy Chinese Medicine Therapy Guideline

Scope

Scope: This document specifies the diagnostic criteria for traditional Chinese medicine (TCM) syndromes and treatment regimens during adjuvant chemotherapy following radical surgery for colorectal cancer. This document is applicable to patients in the adjuvant chemotherapy phase following radical surgery for colorectal cancer. This document is suitable for TCM (integrative TCM) practitioners in oncology departments of hospitals at all levels, as well as Western clinicians who have received TCM training. Relevant nursing staff and pharmacists may also refer to it. Main technical content: Foreword II Introduction III 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Epidemiological characteristics of colorectal cancer during chemotherapy 5 Pathogenesis and etiology of colorectal cancer during chemotherapy 5.1 Modern medical etiology and pathogenesis 5.2 TCM etiology and pathogenesis 6 TCM diagnosis and syndrome differentiation 6.1 Basis for TCM diagnosis and syndrome differentiation 6.2 Spleen-stomach disharmony syndrome 6.3 Spleen-kidney deficiency syndrome 6.4 Exogenous wind-heat syndrome 7 Treatment 7.1 Recommended prescriptions based on TCM syndrome differentiation during colorectal cancer chemotherapy 7.2 TCM treatment methods and precautions 8.3 Application of traditional Chinese medicines and usage precautions 9 Clinical issues, recommendations, and evidence descriptions 10 Appendix A (informative) 11 Members of the document preparation team 12 Appendix B (informative) 13 Evidence grading recommendations and methodological quality evaluation standards 14 Appendix C (informative) 15 TNM staging proposed by the 2017 AJCC Cancer Staging Manual (8th Edition) 16 Appendix D (informative) 17 Evidence sources and evidence screening process 18 Appendix F (informative) 19 Evidence retrieval process 20 Appendix G (informative) 21 References

Development Information

Related Standards